{"id":"https://openalex.org/W4210878397","doi":"https://doi.org/10.3389/fonc.2022.823705","title":"Effects of Concomitant Antibiotics Use on Immune Checkpoint Inhibitor Efficacy in Cancer Patients","display_name":"Effects of Concomitant Antibiotics Use on Immune Checkpoint Inhibitor Efficacy in Cancer Patients","publication_year":2022,"publication_date":"2022-02-09","ids":{"openalex":"https://openalex.org/W4210878397","doi":"https://doi.org/10.3389/fonc.2022.823705","pmid":"https://pubmed.ncbi.nlm.nih.gov/35223505","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8864310"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2022.823705","doi":"https://doi.org/10.3389/fonc.2022.823705","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.823705","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2022.823705/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fonc.2022.823705/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054482344","display_name":"Shuai Jiang","orcid":"https://orcid.org/0000-0003-1235-6269","observed_orcids":["https://orcid.org/0000-0003-1235-6269"]},"institutions":[{"id":"https://openalex.org/I4210103956","display_name":"Third Affiliated Hospital of Harbin Medical University","ror":"https://ror.org/01f77gp95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103956"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shuai Jiang","raw_affiliation_strings":["Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China","institution_ids":["https://openalex.org/I4210103956"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086312529","display_name":"Shuai Geng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shuai Geng","raw_affiliation_strings":["Department of Pharmacy, Strategic Support Force Medical Center, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Strategic Support Force Medical Center, Beijing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Qian Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qian Chen","raw_affiliation_strings":["Department of Pharmacy, Beijing Boren Hospital, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Beijing Boren Hospital, Beijing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100374123","display_name":"Chen Zhang","orcid":"https://orcid.org/0000-0002-5080-9321","observed_orcids":["https://orcid.org/0000-0002-5080-9321"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chen Zhang","raw_affiliation_strings":["Department of Medical Imaging, Strategic Support Force Medical Center, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Imaging, Strategic Support Force Medical Center, Beijing, China","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069157560","display_name":"Mengfei Cheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103956","display_name":"Third Affiliated Hospital of Harbin Medical University","ror":"https://ror.org/01f77gp95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103956"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Mengfei Cheng","raw_affiliation_strings":["Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China","institution_ids":["https://openalex.org/I4210103956"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103659772","display_name":"Yang Yu","orcid":"https://orcid.org/0000-0002-1743-7458","observed_orcids":["https://orcid.org/0000-0002-1743-7458"]},"institutions":[{"id":"https://openalex.org/I4210103956","display_name":"Third Affiliated Hospital of Harbin Medical University","ror":"https://ror.org/01f77gp95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103956"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yang Yu","raw_affiliation_strings":["Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China","institution_ids":["https://openalex.org/I4210103956"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110379438","display_name":"Shuo Zhang","orcid":"https://orcid.org/0009-0007-2865-5358","observed_orcids":["https://orcid.org/0009-0007-2865-5358"]},"institutions":[{"id":"https://openalex.org/I4210103956","display_name":"Third Affiliated Hospital of Harbin Medical University","ror":"https://ror.org/01f77gp95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103956"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shuo Zhang","raw_affiliation_strings":["Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China","institution_ids":["https://openalex.org/I4210103956"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ning Shi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ning Shi","raw_affiliation_strings":["Department of Pharmacy, Strategic Support Force Medical Center, Beijing, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Strategic Support Force Medical Center, Beijing, China","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101765229","display_name":"Mei Dong","orcid":"https://orcid.org/0000-0001-9688-5189","observed_orcids":["https://orcid.org/0000-0001-9688-5189"]},"institutions":[{"id":"https://openalex.org/I4210103956","display_name":"Third Affiliated Hospital of Harbin Medical University","ror":"https://ror.org/01f77gp95","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210103956"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Mei Dong","raw_affiliation_strings":["Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, Harbin Medical University Cancer Hospital, Harbin, China","institution_ids":["https://openalex.org/I4210103956"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5101765229"],"corresponding_institution_ids":["https://openalex.org/I4210103956"],"apc_list":{"value":2950,"currency":"USD","value_usd":2950},"apc_paid":{"value":2950,"currency":"USD","value_usd":2950},"fwci":0.7263,"has_fulltext":true,"cited_by_count":32,"citation_normalized_percentile":{"value":0.65023847,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"12","issue":null,"first_page":"823705","last_page":"823705"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10066","display_name":"Gut microbiota and health","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9900000095367432},{"id":"https://openalex.org/keywords/gut-microbiota","display_name":"gut microbiota","score":0.9779999852180481},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8320000171661377},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":1.0},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8889999985694885},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":1.0},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9950000047683716},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7080000042915344}],"concepts":[{"id":"https://openalex.org/C60962613","wikidata":"https://www.wikidata.org/wiki/Q287654","display_name":"ABX test","level":2,"score":0.989961564540863},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8534825444221497},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7049857378005981},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.65692138671875},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6133204698562622},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5695019364356995},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.5041447877883911},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.48313042521476746},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.40317532420158386},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.27933791279792786},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2022.823705","doi":"https://doi.org/10.3389/fonc.2022.823705","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.823705","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2022.823705/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8864310","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8864310","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmid:35223505","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35223505","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Systematic Review"},{"id":"pmh:oai:doaj.org/article:68dd816d2c754d2db105f8952a435532","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/68dd816d2c754d2db105f8952a435532","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 12 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2022.823705","doi":"https://doi.org/10.3389/fonc.2022.823705","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2022.823705","pdf_url":"https://www.frontiersin.org/articles/10.3389/fonc.2022.823705/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320312270","display_name":"Harbin Medical University","ror":"https://ror.org/05jscf583"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4210878397.pdf","grobid_xml":"https://content.openalex.org/works/W4210878397.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W2033649854","https://openalex.org/W2122194486","https://openalex.org/W2185075416","https://openalex.org/W2745821596","https://openalex.org/W2765314233","https://openalex.org/W2767287110","https://openalex.org/W2782333299","https://openalex.org/W2791483720","https://openalex.org/W2795186863","https://openalex.org/W2796582438","https://openalex.org/W2797443945","https://openalex.org/W2888059202","https://openalex.org/W2892640821","https://openalex.org/W2909988858","https://openalex.org/W2912325577","https://openalex.org/W2918152867","https://openalex.org/W2919663648","https://openalex.org/W2925446385","https://openalex.org/W2942123458","https://openalex.org/W2942824536","https://openalex.org/W2961510294","https://openalex.org/W2975538531","https://openalex.org/W2976586374","https://openalex.org/W2980072580","https://openalex.org/W2985762613","https://openalex.org/W2987253676","https://openalex.org/W2990381272","https://openalex.org/W2990726636","https://openalex.org/W2991035654","https://openalex.org/W2995076193","https://openalex.org/W2999666394","https://openalex.org/W3011314376","https://openalex.org/W3095710530","https://openalex.org/W3124384511","https://openalex.org/W3178490306","https://openalex.org/W3194875966","https://openalex.org/W3204478304","https://openalex.org/W4255727347"],"related_works":["https://openalex.org/W4286297394","https://openalex.org/W3088904814","https://openalex.org/W4322767412","https://openalex.org/W3121241747","https://openalex.org/W2976586374","https://openalex.org/W3112358052","https://openalex.org/W3008549813","https://openalex.org/W3012989060","https://openalex.org/W7134192411","https://openalex.org/W3120296211"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Immune":[1],"checkpoint":[2],"inhibitors":[3],"(ICIs)":[4],"have":[5],"changed":[6],"the":[7,26,47,53,145],"outcomes":[8],"of":[9,12,29,49,55,72,83,109,148,166],"a":[10,21],"variety":[11],"cancers":[13],"in":[14,25,121,144,179],"an":[15],"unprecedented":[16],"manner.":[17],"Gut":[18],"microbiome":[19],"plays":[20],"crucial":[22],"regulatory":[23],"role":[24],"antineoplastic":[27],"therapy":[28],"ICIs,":[30],"which":[31],"can":[32],"be":[33,176],"influenced":[34],"by":[35],"antibiotic":[36],"(ABX)":[37],"administration.":[38],"In":[39],"this":[40,122],"efficacy":[41,123],"evaluation,":[42],"we":[43],"aimed":[44],"to":[45,191],"clarify":[46],"correlations":[48,82],"ABX":[50,84,125,161,174],"administration":[51,85,126],"with":[52,86,101],"survival":[54,88,92],"cancer":[56,114,152,167,180],"patients":[57,115,181],"receiving":[58,116,182],"ICIs":[59,117,164],"treatment.":[60],"METHOD:":[61],"The":[62,81],"eligible":[63],"literatures":[64],"were":[65,94,119,142],"searched":[66],"using":[67,96],"PubMed,":[68],"Cochrane":[69],"Library,":[70],"Web":[71],"Science,":[73],"and":[74,90,135,158,172],"Clinical":[75],"trials.gov":[76],"databases":[77],"before":[78],"Nov":[79],"2021.":[80],"progression-free":[87],"(PFS)":[89],"overall":[91],"(OS)":[93],"determined":[95],"Hazard":[97],"ratios":[98],"(HRs)":[99],"coupled":[100],"95%":[102],"confidence":[103],"intervals":[104],"(CIs).":[105],"RESULTS:":[106],"A":[107],"total":[108],"12":[110],"studies":[111],"enrolling":[112],"6010":[113],"treatment":[118,165],"included":[120],"evaluation.":[124],"was":[127],"significantly":[128,169],"correlated":[129],"worse":[130],"PFS":[131,171],"(HR=1.60,":[132],"95%CI=1.33-1.92,":[133],"P<0.00001)":[134],"OS":[136],"(HR=1.46,":[137],"95%CI=1.32-1.61,":[138],"P<0.00001).":[139],"Similar":[140],"results":[141],"found":[143],"subgroup":[146],"analysis":[147],"non-small":[149],"cell":[150,155],"lung":[151],"(NSCLC),":[153],"renal":[154],"carcinoma":[156],"(RCC)":[157],"melanoma.":[159],"CONCLUSIONS:":[160],"use":[162],"during":[163],"may":[168],"shorten":[170],"OS.":[173],"should":[175],"used":[177],"cautiously":[178],"ICIs.":[183],"However,":[184],"further":[185],"validations":[186],"are":[187],"still":[188],"essential":[189],"due":[190],"existing":[192],"publication":[193],"bias.":[194]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":3},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-02-09T00:00:00"}